WELCOME TO CANCER CONNECTION, a monthly online publication featuring the latest news and information for faculty and staff at Ohio State’s Comprehensive Cancer Center – James Cancer Hospital and Solove Research Institute (OSUCCC – James). If you have a news item for the next Cancer Connection, call 293-6825 or send an email message to robert.hecker@osumc.edu by Tuesday, December 20.
OSUCCC Director and James CEO Michael A. Caligiuri, MD, delivers
his 2016 State of the Cancer Program Address to a capacity audience in 115 BRT.
Caligiuri
Delivers Annual ‘State of the Cancer Program
Address’ OSUCCC – JAMES MAKING ‘EVER-BIGGER FOOTPRINT’ IN CANCER
CARE Ohio State’s
cancer program is placing “an ever-bigger footprint around the globe” as it
continues to make an impact in research, compassionate care and community
relationships, OSUCCC Director and James CEO Michael A. Caligiuri, MD,
said during his “State of the Cancer Program Address.”
“The impact we’re
making couldn’t come soon enough,” Caligiuri said on Nov. 9 when addressing a
capacity audience in Room 115 of Ohio State’s Biomedical Research Tower. “I get
calls almost every day from people who are desperate for help. It’s really neat
for them to learn that help is on the way” via all that the OSUCCC – James has
to offer through its research-based cancer care. Read more
STATEWIDE LUNG CANCER CLINICAL RESEARCH INITIATIVE TO BE LAUNCHED The OSUCCC – James is set to launch a statewide clinical research initiative that takes aim at lung cancer, the No. 1 cancer killer among men and women in the United States.
Led by Peter Shields, MD, David Carbone, MD, PhD, and Mary Ellen Wewers, RN, PhD, MPH, the initiative is called Beating Lung Cancer - in Ohio (BLC-IO) and will be supported by a $3 million grant from Pelotonia, the annual grassroots bicycle tour that raises money for cancer research at Ohio State.
The initiative will draw upon an existing network of more than 50 partner hospitals from communities across Ohio that was established as part of the Ohio Colorectal Cancer Prevention Initiative (OCCPI), a previous statewide research initiative funded by Pelotonia. Recruitment for the new initiative will take place over three years starting in March 2017. Read more
PELOTONIA
16 RAISES OVER $24 MILLION FOR CANCER RESEARCH AT OHIO STATE Pelotonia, a grassroots organization that
raises money for cancer research at the OSUCCC – James, announced at a ceremony
on Nov. 9 that riders, virtual riders and volunteers raised a record
$24,104,432 through the 2016 ride, bringing the organization’s eight-year total
to $130,159,438.
Donors from all 50 states and
more than 60 countries contributed to the funds raised by the 275 pelotons
(riding groups) in Pelotonia 16, which was the eighth installment of this
annual tour that began in 2009. Specifically in Columbus on Aug. 6-7, 7,749
riders and 2,790 volunteers from 40 states and eight countries participated in
six routes that ranged from 25 to 180 miles.
The 2017 Pelotonia
ride is scheduled for Aug. 4-6. Rider registration will open on Feb. 8 at pelotonia.org. Read more
NEW
DIRECTOR FOR DIVISION OF MEDICAL ONCOLOGY TO START JUNE 1 Claire Verschraegen, MD, MS, director of Hematology/Oncology at
the University of Vermont, will become the new director of the Division of
Medical Oncology in the Department of Internal Medicine at Ohio State on June
1, when she also will become associate director for translational research at
the OSUCCC – James. Her appointments were announced Nov. 22 by OSUCCC Director
and James CEO Michael A. Caligiuri, MD,
and Michael R. Grever, MD, professor
and chair of the Department of Internal Medicine at Ohio State, where he also
serves as associate dean for medical services in the College of Medicine. Read more
HOLIDAY SEASON TO
FEATURE SEVERAL SPECIAL EVENTS
Cancer program
holiday receptions, a progressive sale at Scarlet Ribbon Gift Shops, and the
annual Santa Rounds & caroling on patient floors at The James are among
several special events scheduled in observance of the holiday season at the
OSUCCC – James. A full schedule of events
is attached as a flier
for printing and posting.
SURVEY:
MAJORITY UNDER 35 THINK E-CIGS ARE SAFER; STUDIES AIM TO FIND OUT Most Americans under age 35 think that using electronic
cigarettes does not cause as much damage to lung health as compared with
traditional cigarettes, according to the results of a new national consumer
survey.
In the survey, which included
more than 2,000 people under 35, 44 percent of respondents reported believing
that e-cigarettes are less harmful to the lungs than traditional cigarettes.
Among men, that number jumped to 54 percent who think e-cigarettes are safer.
“The truth is there is just
so much we don't know about these new products,” says Peter Shields, MD, a thoracic oncologist and deputy director of the
OSUCCC – James, where he also is in the Cancer Control Program. “We have no
idea where in the spectrum these are, in terms of safety. Are they like
cigarettes, or nothing like cigarettes? Do they affect people the same if
they’ve never smoked, or a lot worse? We need to figure this out.” Read more
MARK CALENDARS FOR
‘STATE OF RESEARCH’ ADDRESS, INNOVATOR AWARDS
Caroline Whitacre, PhD, senior vice president for Research at Ohio
State, will deliver her annual State of
Research Address and announce the 2016 Innovator of the Year awards at 8:30
a.m. on Wednesday, Jan. 25, in the U.S. Bank Conference Theater at the Ohio
Union.
Whitacre will talk
about the breadth, scope and excellence of Ohio State’s research programs and
announce the recipients of the 2016 Innovator of the Year, Early Career
Innovator of the Year and Student Innovator of the Year awards.
Immediately following
those announcements, a reception honoring the award recipients will be held in
Woody’s Tavern at the Ohio Union. If you wish to attend these events, please RSVP. Questions?
Contact Beth Haas at haas.23@osu.edu or 614-688-4725.
APPLICANTS
SOUGHT FOR TL1 MENTORED CLINICAL RESEARCH TRAINING PROGRAM
The Ohio State University Center for Clinical and Translational Science (CCTS)
is seeking applicants for the TL1 Mentored Clinical Research Training Program.
The TL1 award supports pre- and postdoctoral trainees who want a practical
introduction to clinical and translational research. The program goal is to
increase the number of well-trained clinician-scientists who can design and
oversee clinical investigations leading to faster delivery of new treatments to
patients. An information session about the program is set for noon-1 p.m. on Saturday, March 4, in
Room 240 Prior Hall. Register
NEW NIH POLICY ON GOOD CLINICAL PRACTICE TRAINING EFFECTIVE JAN. 1 Effective Jan. 1, all NIH-funded investigators and staff who are involved in the conduct, oversight or management of clinical trials should be trained in Good Clinical Practice (GCP). GCP training complements other required training on protections for human subjects research. It provides a standard for ensuring clinical trial compliance, implementation, data collection, monitoring and reporting (e.g., safety data, accrual reports, study status, protocol deviations, unanticipated problems or final data) and outlines the responsibilities of Institutional Review Boards (IRBs), investigators, sponsors and monitors.
NCCN SEEKS GRANT FUND PROPOSALS FOR LUNG CANCER DRUG STUDY The National Comprehensive Cancer Network (NCCN) has received a research grant from AstraZeneca Pharmaceuticals, LP to support NCCN investigator-initiated clinical, preclinical and correlative studies of TAGRISSO™ (osimertinib) in treating systemic or CNS EGFRm+ non-small cell lung cancer and is requesting proposals for using this money. The RFP can be accessed online by signing in as a member at NCCN.org/clinical_trials/investigators.
Investigators are asked to submit a proposal detailing their prospective research studies. It is hoped that the proposals will prove useful in guiding further development of TAGRISSO™ (osimertinib). Studies with correlative endpoints and collaborative studies between NCCN member institutions are encouraged. Proposals are due by 5 p.m. EST on Thursday, Jan. 12. For additional information, contact Doreen Walker, administrative assistant, Oncology Research Program, at (215) 690-0565 or via e-mail at Walker@nccn.org.
CURRENT RESEARCH DEVELOPMENT & GRANT
WRITING
NEWS AVAILABLE
The latest issue of Research
Development & Grant Writing News is available at go.osu.edu/grantwritingnews. This monthly newsletter contains
articles and links to resources on the Web. Topics this month include:
- Planning for Success at NSF
- The Editorial "Clawback" on Page Overruns
- What's your Problem? What's Your Solution?
- Initiative to Strengthen Agricultural Workforce
- The Stepwise Path from Ideas to Dollars
- Agency Research News, Reports, Workshops &
Roadmaps
- New Funding Opportunities
TRANSLATIONAL THERAPEUTICS PROGRAM SEMINAR
DEC. 15 – Carter Van Waes, MD, PhD, Clinical Director,
National Institute on Deafness and Other Communication Disorders, and Chief,
Head and Neck Surgery Branch and Tumor Biology Section, Division of Intramural
Research, National Institutes of Health, Bethesda, Md., Noon-1 p.m., 115 BRT, “Genomics and Personalized
Medicine for Head and Neck Cancer.” Lunch will be provided.
CANCER CONTROL PROGRAM SEMINAR
DEC. 21 – Ted Brasky, PhD, Research Assistant Professor, Division of
Cancer Prevention and Control, College of Medicine; Ashley Felix, PhD, Assistant Professor,
Division of Epidemiology, College of Public Health; Ashley Rosko, MD, Assistant
Professor-Clinical, Division of Hematology, College of Medicine; Tasleem Padamsee, PhD, Assistant Professor,
Division of Health Services Management and Policy, College of Public Health; Micah Berman, JD, Assistant Professor,
Division of Health Service Management and Policy, College of Public Health, and
Moritz College of Law (all presenters from Ohio State), Noon-1 p.m., L035
James, “Five
Updates on K Proposals.” Lunch will be provided.
The
2016-17 OSUCCC – James Grand Rounds series continues on selected Fridays
throughout the academic year. All lectures will be from 8-9 a.m. in L035 James
(Wasserstrom Family Conference Room) on the Conference Level unless otherwise
noted. Below is a list of upcoming Grand Rounds presentations. Watch Cancer Connection and the Weekly Cancer Event Update
for updates and details.
JAN. 6 – Joshua Lang, MD, MS, Assistant Professor, Department of Medicine, Division of
Hematology/Oncology, University of Wisconsin; Clinical Co-Chair, Precision
Medicine Molecular Tumor Board, University of Wisconsin Carbone Cancer Center
JAN. 20 – Rebecca Jacobson, MD, MS, Professor, Department of Biomedical Informatics, University
of Pittsburgh Medical School
FEB. 3 – Ehud Mendel, MD, FACS, Professor
of Neurological Surgery, Oncology, Orthopaedics and Systems Engineering at Ohio
State; Justine Skestos Chair in Minimally Invasive Neurological Spinal Surgery;
Director, Spine Program, Complex Oncological Fellowship Program; Clinical
Director, The Ohio State University Spine Research Institute; President-Elect,
The Ohio State Neurosurgical Society, “Surgical
Management of Spine Tumors” Biosketch
MARCH 3 – Clara D.
Bloomfield, MD, Distinguished
University Professor at The Ohio State University; Cancer Scholar and Senior
Adviser at the OSUCCC – James, “New World Health Organization and European LeukemiaNet AML
Classifications”
JAMES NURSING GRAND
ROUNDS
(All lectures
will be in L045 James unless otherwise noted.)
DEC. 14 – Various speakers will talk about the
body of work presented by James nurses at 2016 national conferences. This
session will be from 1-2 p.m.
Medical scientists at the
OSUCCC – James frequently publish cancer-related articles in prestigious
scientific journals. View a list of articles that have appeared recently in journals with an
impact factor (IF) of 7.0 or above. Bolded names denote OSUCCC members.
REGISTER FOR OHIO STATE’S 2017 ASH
REVIEW Register now for Ohio State’s 2017 American
Society of Hematology (ASH) Review, a Jan. 20 event that will provide a
comprehensive overlook at advances in the biology, etiology, diagnosis, therapy
and evidence-based management of blood cancers as presented at the 58th
ASH Annual Meeting & Exposition that was held Dec. 3-6 in San Diego.
The ASH Review, to be held from 7:30 a.m.-3:30
p.m. at The Fawcett Center, 2400 Olentangy River Road, will include a keynote
address by Ashley Rosko, MD, assistant professor-clinical in the
Division of Hematology at Ohio State and member of the Cancer Control Program
at the OSUCCC – James. There is no fee to attend the review. Register If you have any questions, contact Sarah.Schmidt (293-5521).
NEXT JAMES OPEN FORUM
IS THURSDAY, JAN. 5
The next monthly
James Open Forum featuring Kris
Kipp, MSN, RN, OSUCCC
– James executive director of patient services and chief nursing officer, will
be held from 8-9 a.m. and 2-3 p.m. on Thursday, Jan. 5,
in L035 James (Wasserstrom Conf. Room) on the Conference Level. These Question
& Answer Forums are held on the first Thursday of each month at the same
times and location to address faculty and staff questions. Your questions and
feedback are welcome. After the January forum, the next ones will be held on
and Feb. 2 and March 2.
DEC. 9 NCCN SUMMIT TO
ADDRESS ‘VALUE TOOLS IN CANCER CARE’
Registration is open
for a National Comprehensive Cancer Network (NCCN) Summit on Value Tools for Patients in
Cancer Care to
be held on Friday,
Dec. 9, from
7:30 a.m.-3 p.m. at The National Press Club, 529 14th St., in Washington, D.C.
This summit will enable a varied group of stakeholders, including patients,
patient advocacy organizations, providers, payers, industry and government, to
discuss current value tools in cancer care that are available for patients. Register &
learn more
REGIONAL NON-SMALL CELL LUNG CANCER SUMMIT SET FOR JAN. 14 Healthcare
providers can improve their knowledge, skill and competence in the assessment
and management of non-small cell lung cancer (NSCLC) by attending a regional
summit titled GAIN: EnGAging an Interdisciplinary Team for NSCLC Diagnosis,
Personalized Assessment & Treatment on Saturday, Jan. 14, in Tampa, Fla. This educational
initiative will consist of pulmonology, thoracic surgery, pathology and
oncology clinicians engaged in various live, enduring and practice-improvement
efforts. Learn More &
Register
NCCN 2017 CONGRESS SERIES™: BREAST CANCER TO UNFOLD FEB. 10 Expert insights on the
current standard of care for patients with breast cancer will be presented at the National Comprehensive Cancer
Network (NCCN) 2017 Congress Series™: Breast Cancer from 7:45 a.m.-3:30 p.m.
CST on Friday, Feb. 10, at Prentice Women’s Hospital in Chicago. This event
also will provide the latest clinical research updates from the 2016 San Antonio
Breast Cancer Syposium to assist clinicians in formulating breast cancer
management strategies. Register
NCCN CASE
MANAGER & MEDICAL DIRECTOR LIVE WEBINARS SLATED Here
are the remaining live webinars for December in the National Comprehensive
Cancer Network (NCCN) Case Manager and Medical Director Program Series:
Dec. 12 – Distress Management – Implementing New Standards of Care
Dec. 14 – Ovarian Cancer – The Value of NCCN
Guideline-Adherent Care
Dec. 16 – Practical Considerations in the
Long-Term Management of Patients with CML
2 PRESENTATIONS LISTED FOR
NCCN IMMUNOTHERAPIES IN CANCER SERIES Here are the remaining
online presentations for December in the National Comprehensive Cancer Network (NCCN)
2016 Congress Series™: Immunotherapies in
Cancer:
Dec. 8 – Melanoma
Dec. 21 – Management of Toxicities Related to Immunotherapies
REGISTRATION OPEN FOR NCCN 22ND ANNUAL
CONFERENCE 2017 Register now for the National Comprehensive
Cancer Network (NCCN) 22nd Annual Conference 2017: Improving the Quality,
Effectiveness and Efficiency of Cancer Care™, which will be held from Thursday,
March 23-Saturday, March 25 at Rosen Shingle Creek in Orlando, Fla.
Early-bird registration fee discounts will expire Monday, Feb. 13. Learn more &
register
The NCCN conference annually
draws more than 1,600 registrants from around the world, including oncologists
(in both community and academic settings), oncology fellows, nurses,
pharmacists and other healthcare professionals involved in the care of patients
with cancer. Respected opinion leaders will present the latest cancer therapies
and provide updates on selected NCCN Clinical Practice Guidelines in Oncology
(NCCN Guidelines®). This year’s agenda includes more than 25 educational
sessions featuring the latest advances in oncology care.
NCCN 2017 ONCOLOGY
NURSING PROGRAM SLATED FOR MARCH 22
Oncology nurses who manage patients with cancer are encouraged to attend the
National Comprehensive Cancer Network (NCCN) 2017 Oncology Nursing Program that
will precede the NCCN 22nd Annual Conference in March at Rosen Shingle Creek in
Orlando, Fla. The Oncology Nursing Program will unfold from 8 a.m.-3 p.m. on
Wednesday, March 22, a day before the start of the March 23-25 NCCN 22nd Annual
Conference at the same location (see story, above).
The Oncology Nursing Program
will provide comprehensive and clinically relevant information designed to
optimize patient education and care. Program agenda topics include: Creating a
Compassionate Workplace; Strategies to Improve the Management of Febrile
Neutropenia; Optimizing the Nursing Role in Difficult Conversations; and
Management of Adverse Dermatologic Effects.
If you are registered for the
Oncology Nursing Program, you are automatically registered for the NCCN Annual
Conference General Sessions on March
23-25; it is not
necessary to register for both programs. Learn more & register for the Oncology Nursing Program
JAMES MEDICAL STAFF
APPOINTMENTS APPROVED The Professional Affairs Committee of the Ohio State Wexner Medical Center
Board of Trustees in November approved the initial appointments of one
attending physician and nine associate attending physicians on The James
medical staff. The new appointees and their departments and divisions (if
applicable) are:
Attending – Gabriel Tinoco Suarez, MD Internal Medicine (Medical Oncology)
Associate Attending – Nour Abou Assalie, MD, Internal Medicine (Hospital Medicine); Mark Bechtel, MD, Internal Medicine
(Dermatology); Bakri Elsheikh, MBBS,
Neurology; Robert Fallis, MD,
Neurology; Irina Livshitz, MD,
Ophthalmology; Jose Moreno, PhD,
Psychiatry (Health Psychology); Imran
Rafique, MBBS, Internal Medicine
(Medical Oncology); Walter Stearns, MD,
Psychiatry; Rajive Tandon, MD,
Internal Medicine (Pulmonary, Allergy, Critical Care and Sleep Medicine)
DATES SET FOR
‘RECONNECTING TO PURPOSE AND PASSION 2017’ Registration is open
for “Reconnecting to Purpose and Passion 2017,” a two-day experiential retreat
that enables participants to engage in the four key relationships of
Relationship-Based Care (care of self, colleagues, patients/families and
community) while reconnecting to their personal and professional passion. The
first workshop of 2017 will be Jan.
12-13. Subsequent workshops will be held Feb. 23-24, April 27-28, Aug. 30-31, Oct. 19-20
and Nov. 16-17.
When registering, provide
session dates and your name, cost center, unit/department and title/role.) Register:
Andrea Pack
JAMES
PATIENT-SATISFACTION SCORES SOAR IN SEPTEMBER The James’ HCAHPS
(Hospital Consumer Assessment of Healthcare Providers and Systems) scores
finished strong in September with top box scores that
were in the top decile for all HCAHPS domains. The September HCAHPS
Overall top box score was 88.9 percent and placed The James in the 98th
percentile. Read more
JAMESCARE FOR LIFE LATE-FALL OFFERINGS LISTED
A Lunch & Learn
presentation on Managing Chemo-Related Memory Loss and a Healing Through Art session are among several offerings scheduled in the weeks ahead as part of the
JamesCare for Life (JCFL) Fall Class
Series, which is designed for those diagnosed with cancer and their caregivers.
All of the offerings are FREE, but registration is required by calling 293-6428
or by visiting cancer.osu.edu/JCFL. You also can read highlights
of December JCFL classes. View the Winter 2017 Class Listing
CALIGIURI FIRESIDE CHAT TO HIGHLIGHT
WINTER JCFL
OFFERINGS OSUCCC Director and James CEO
Michael A. Caligiuri, MD, will present an informative fireside chat about
the future of cancer research, prevention and treatment on Thursday, Feb. 9,
at The Fawcett Center, 2400 Olentangy River Road, as part of the JamesCare
for Life 2017 winter offerings. The doors will open at 5:30 p.m.; the
program will extend from 6-8 p.m.
Guests will learn more about
some of the research discoveries and new cancer therapies at Ohio State while
listening to one of the world’s leading cancer experts talk about how everyone
at the OSUCCC – James is working together to create a cancer-free world.
Light
appetizers will be served, and free on-site parking will be available. A
parking pass (to be displayed on dashboards) will be emailed to registrants one
week before the program. Register
This
program will also be available to view online via live stream. Email jamescareforlife@osumc.edu
for viewing instructions.
HIPAA CBL REQUIREMENT
REMINDER ISSUED
As announced earlier this year, required annual eLearning deadlines will change
to June 30 of each year, including the HIPAA CBL. (Please note that the
deadline to complete the Flu CBL for those requesting an exemption from the flu
shot is Dec.
1 each year.) To
ease this transition—this year only—faculty and staff will have until June 30, 2017, to complete all other CBLs,
including HIPAA CBLs. This grace period will allow a smoother transition and
give staff more time to acclimate to this change. Click here to complete your CBLs and other
training, or to register for classes.
REGISTER
TO RECEIVE BUCKEYE ALERTS
If your cell phone number
is already in Employee Self Service (for faculty/staff) or BuckeyeLink (for
students), you are automatically registered for the Buckeye Alert text
messaging system. Faculty, staff and students have the ability to register up
to two additional cell phone numbers to receive text message notifications.
These additional phone numbers can belong to parents, spouses or anyone else
they wish to include in the text message notifications. To add / update
your cell phone number and get more information, read about alert notices.
BUILDING
RELATIONSHIPS WITH DIGITAL STRATEGY ACROSS OHIO STATE In addition
to the OSUCCC – James blog,
The Ohio State University Wexner Medical Center (OSUWMC) recently launched a blog
focused on providing helpful tips on health-related topics to ease healthcare
decisions.
The focus of the OSUCCC – James blog is to
provide information on cancer research, treatment and healthy living for cancer
patients and their caregivers, while this new community blog aims to provide
useful, general health and wellness information from OSUWMC experts. Both blogs
offer helpful information on managing one’s health and the health of loved
ones. Relevant blog stories will also be posted to OneSource.
REMEMBRANCE
AND RENEWAL OPPORTUNITY EXTENDS THROUGH FRIDAY Faculty and
staff are encouraged to visit Room 061 on the ground floor of the new Brain
& Spine Hospital for a self-guided Remembrance and Renewal experience to
recall those who have impacted your life personally and professionally; honor
patients, families and friends to whom you have provided compassionate care;
celebrate life and the sacredness of relationships; and renew your mind, body
and spirit. The opportunity became available at noon on Monday, Dec. 5, and
will extend until 5 p.m. on Friday, Dec. 9. Room 061 is located through
the lobby of the Neuro-Oncology Clinic, toward the left and straight back (last
room on the left before the restrooms).
TIME TO REGISTER FOR
‘STEP UP FOR STEFANIE’S CHAMPIONS’
Registration is open for Step Up for Stefanie's Champions 2017, presented by
Panera Bread. Cancer survivors are encouraged to honor the champions in their
lives by participating in the one- or four-mile walk/run on Saturday, April 22. The event will begin and end at the
Stefanie Spielman Comprehensive Breast Center, 1145 Olentangy River Road. Learn more about nominating your champion
and/or signing up to participate in this event.
SET SAIL WITH 2017
BUCKEYE CRUISE FOR CANCER
Make your reservation today for the 2017 Buckeye Cruise for Cancer, which will
take place from Saturday,
Feb. 25-Thursday, March 2,
to raise money for the Urban and Shelley Meyer Fund for Cancer Research and the
OSUCCC – James. Guests will be traveling on Royal Caribbean’s Independence of
the Seas cruise ship from Fort Lauderdale, Fla., to Buckeye Island (CocoCay, Royal Caribbean’s private island), and Nassau, Bahamas. 2017 will mark
the 10th anniversary of the cruise, which over the years has helped raise over
$7 million for cancer research. Learn more and
book your cruise
COMMUNITY PARTNER
FUNDRAISERS PLANNED
Shown below are
upcoming Community Partner fundraisers that will benefit the OSUCCC – James:
Raise
a Racket for Cervical Cancer Awareness The Crawford
Crew will hold the fifth annual Raise A Racket to raise money for the fight
against cervical cancer on Saturday, Jan. 21, from 4-9 p.m. at Wickertree
Tennis & Fitness, 5760 Maple Canyon Ave. The day will include tennis
clinics and competitions with the pros, silent auction, raffle, live music, a
variety of foods from local restaurants in Columbus, beverages and a speaking
program. Proceeds will benefit The Diane Crawford Cervical Cancer Research,
Education, Outreach Fund. Those who register by Dec. 15 will receive a 17 oz.
Raise A Racket double wall stainless steel bottle. For more information, visit www.thecrawfordcrew.org or
contact diane.kay.crawford@gmail.com.
Cards
to Cure Cancer Join the
Buckeye Alumni Cheerleaders for their annual poker tournament on Jan. 22 at the
Hollywood Casino, 200 Georgesville Road, Columbus. Registration will start at 9
a.m.; cards will fly at 11 a.m. Joining this event, which will benefit The
Urban and Shelley Meyer Fund for Cancer Research, will be poker superstar Mike
Sexton, a World Series of Poker winner, Ohio State graduate and professional
poker commentator. Buckeye greats scheduled to appear are Jake Ballard, Terence
Dials, Raymont Harris, Branden Joe, Scoonie Penn, Antonio Pittman, Anthony
Schlegel, J.J. Sullinger, Granville Waiters, Beanie Wells and Justin Zwick.
Sponsorships and individual player entries are available. For more information,
visit www.cardstocurecancer.com.
SPAGIO - Travel the World with Chef Mehta On
Sunday, March 19, Spagio will host Chef Jehangir Mehta, chef and owner of
Graffiti, Me and You, at 4 p.m. in the Spagio Wine Lounge. Guests can take a virtual
taste tour of the world as Mehta guides them through his favorite global dining
experiences. The cost is $250 per person. Advance reservations are required;
seating is limited. Proceeds will benefit the Radiation Oncology Fund at the
OSUCCC – James. For more information, visit www.spagio.com.
SPAGIO - An Intimate Dinner with Jehangir Mehta On
Monday, March 20, at 6 p.m. at the Aubergine Private Dining Club, enjoy
an intimate multi-course dinner prepared by the award-winning Chef Jehangir
Mehta. In addition, Master Sommeliers Matthew Citriglia and Larry O'Brien will
compete for best paired wines per course. Advance reservations are
required; seating is limited. Proceeds will benefit the Radiation Oncology Fund
at the OSUCCC – James. For more information, visit www.spagio.com.
Breath
of Hope Gala This black tie
gala, set for April 22 at L Brands Inc., 2 Limited Parkway, will include
dinner, live and silent auctions, and a chance to hear inspirational survivor
stories. Proceeds will benefit the Blue Beautiful Skies Fund for Lung Cancer
Research. For more information visit www.breathofhopeohio.com or
contact Wendy Hauswirth.
George
R. Tuckett Memorial Golf Scramble This
17th annual golf outing will be held on Saturday, June 17, starting at 7:45 a.m.
at Westchester Golf Course in memory of George Tuckett, who lost his battle
with cancer. Proceeds—raised by team registration, sponsorships, auction items
and donations—will benefit the Cancer Strategic Support Fund. For more
information, contact Matt Wolfe at wolfem6@gmail.com.
The Ohio State
University College of Pharmacy will present the OSUCCC – James with a Friend
of the College Award at the college’s Spring Research Day on April 6. Henry
Mann, PharmD, professor and dean of the College of Pharmacy, says this
award, which is presented at varying intervals when outstanding candidates are
identified, “recognizes an individual and/or individuals who are non-alumni for
continuous thoughtful contributions to the growth and success of the college
through ongoing service and support of the OSU Pharmacy Alumni Society and its
students, faculty and staff.” In a memo to OSUCCC Director and James CEO Michael
A. Caligiuri, MD—as well as Senior Executive Director Jeff A. Walker,
MBA; OSUCCC Deputy Director Peter Shields, MD; Department of
Internal Medicine Professor and Chair Michael R. Grever, MD; and
Division of Hematology Director John C. Byrd, MD—Mann said the award “is
just one way we can say thank you for the great support you have provided in
recruiting faculty to the college and for the shared commitment we have to
ending cancer.”
On Nov. 16, The Ohio State
University signed an agreement with Nanobio Delivery Pharmaceutical Co. Ltd.
for $1.4 million to support the set-up of a Center for RNA
Nanotechnology and Nanomedicine for cancer research. The director of the new
center is Peixuan Guo, PhD, a
professor in the College of Pharmacy who also holds the Sylvan Frank Endowed
Chair of Drug Delivery and is a member of the Translational Therapeutics
Program at the OSUCCC – James. Guo, whose major research interest is applying
RNA nanotechnology to cancer therapy, says 15 people attended the signature
ceremony. Shown above (seated from left) are Guo; Haibo Hu, CEO of Nanobio
Delivery Pharmaceutical Co. Ltd.; Cynthia
Carnes, PharmD, PhD, associate dean of the College of Pharmacy; and (standing
from left) Kristy Baker, director of
the Office for Business & Industry Contracts at Ohio State; Matt McNair, vice president of economic
& corporate engagement at Ohio State; David
Mess, senior technology licensing manager – life science at Ohio State; and Maggie
Merry, chief administrative officer for the College of Pharmacy.
|